Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
460
-
Total 13F shares, excl. options
-
36.5M
-
Shares change
-
+413K
-
Total reported value, excl. options
-
$13.9B
-
Value change
-
+$173M
-
Put/Call ratio
-
0.69
-
Number of buys
-
211
-
Number of sells
-
-218
-
Price
-
$381.93
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2021
513 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2021.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 460 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.5M shares
of 152M outstanding shares and own 23.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.57M shares), VANGUARD GROUP INC (3.71M shares), BAMCO INC /NY/ (1.5M shares), BROWN CAPITAL MANAGEMENT LLC (1.34M shares), Neuberger Berman Group LLC (1.18M shares), Ownership Capital B.V. (1.07M shares), Jackson Square Partners, LLC (945K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (905K shares), STATE STREET CORP (896K shares), and DF DENT & CO INC (868K shares).
This table shows the top 460 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.